Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy
Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common chronic liver diseases, primarily caused by metabolic disorders and systemic inflammatory responses. Although the incidence of MASH is gradually ...
Jul 16, 2024
0
0